SYPL1 and neoplasm: Elevated SYPL1 expression is associated with poor prognosis, while its downregulation—either directly or via circ_0004104 knockdown—suppresses tumor growth, suggesting SYPL1 may serve as a potential marker for cancer progression and treatment response in CRC.